For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Rituximab After ASCT | Rituximab 375 mg/m2 starting 6 weeks after ASCT transplant, and for the 5th and subsequent subjects, a second course at the same dose 6 months after ASCT | None | None | 33 | 35 | 9 | 35 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Blood and lymphatic system disorders - Other, neutropenia | None | Blood and lymphatic system disorders | CTCAE v4 | View |
| Febrile Neutropenia | None | Blood and lymphatic system disorders | CTCAE v4 | View |
| Pneumonitis, BCNU-related | None | Respiratory, thoracic and mediastinal disorders | CTCAE v4 | View |
| Death NOS, pneumonitis | None | General disorders | CTCAE v4 | View |
| Respiratory, thoracic and mediastinal disorders - Other, Community acquired pneumonia | None | Respiratory, thoracic and mediastinal disorders | CTCAE v4 | View |
| Pleural effusion | None | Respiratory, thoracic and mediastinal disorders | CTCAE v4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Blood and lymphatic system disorders - Other, neutropenia | None | Blood and lymphatic system disorders | CTCAE v4 | View |
| Blood and lymphatic system disorders - Other, Thrombocytopenia | None | Blood and lymphatic system disorders | CTCAE v4 | View |
| Anemia | None | Blood and lymphatic system disorders | CTCAE v4 | View |